COR
Cencora, Inc.
Cencora, Inc. insider trading
Cencora, Inc. files with the SEC as a Wholesale-Drugs, Proprietaries & Druggists' Sundries company headquartered in Conshohocken, PA. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
From SEC filings
Recent COR insider transactions
6 insiders traded COR on the open market between Feb 20, 2026 and Sep 16, 2026 — 3 purchases worth $2.3M, 4 sales worth $5.7M, of which 2 were pre-scheduled under a 10b5-1 plan.
- Bought
- $2.3M
- Sold
- $5.7M
- Net
- −$3.4M
- Insiders
- 6
2 of 4 on a 10b5-1 plan
Greenberg Lon R
Director
−$411.3K
Sep 16, 2026
1,280 sh · $321.30
Krikorian Lazarus10b5-1
SVP & Chief Accounting Officer
−$321.1K
Sep 01, 2026
985 sh · $325.97
Campbell Elizabeth S
Executive Vice President
−$3.7M
Aug 24, 2026
11,300 sh · $324.12
Tyler Lauren M
Director
+$148.6K
Jun 22, 2026
550 sh · $270.23
Durcan Dermot Mark
Director
+$1.1M
Jun 18, 2026
4,000 sh · $274.19
Durcan Dermot Mark
Director
+$1.1M
May 28, 2026
4,000 sh · $266.26
Mauch Robert P.10b5-1
President & CEO · Director
−$1.4M
Feb 20, 2026
3,762 sh · $358.94
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Sep 16, 2026 | Greenberg Lon RDirector | 1,280 | $321.30 | −$411.3K |
| Sep 01, 2026 | Krikorian Lazarus10b5-1SVP & Chief Accounting Officer | 985 | $325.97 | −$321.1K |
| Aug 24, 2026 | Campbell Elizabeth SExecutive Vice President | 11,300 | $324.12 | −$3.7M |
| Jun 22, 2026 | Tyler Lauren MDirector | 550 | $270.23 | +$148.6K |
| Jun 18, 2026 | Durcan Dermot MarkDirector | 4,000 | $274.19 | +$1.1M |
| May 28, 2026 | Durcan Dermot MarkDirector | 4,000 | $266.26 | +$1.1M |
| Feb 20, 2026 | Mauch Robert P.10b5-1President & CEO · Director | 3,762 | $358.94 | −$1.4M |
SEC Form 4 data, Q3 2024 to Q2 2026
COR insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 9 insiders traded COR on the open market: 3 purchases worth $2.3M and 50 sales worth $1.5B, 33 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 3 purchases ($2.3M) and 16 sales ($34.6M), by 7 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$2.3M3 buys | — | |
| Q1 2026 | — | −$3.6M3 sales · all on a plan | |
| Q4 2025 | — | −$9M7 sales · 4 on a plan | |
| Q3 2025 | — | −$22M6 sales · all on a plan | |
| Q2 2025 | — | −$19.9M10 sales · 6 on a plan | |
| Q1 2025 | — | −$327.5M14 sales · 10 on a plan | |
| Q4 2024 | — | −$23.3M5 sales · 1 on a plan | |
| Q3 2024 | — | −$1.1B5 sales · 3 on a plan |
- Largest purchase
- +$1.1M of COR by Durcan Dermot Mark (Director) on Jun 18, 2026.
- Largest sale
- −$1.1B of COR by Walgreens Boots Alliance Holdings LLC (10% Owner) on Aug 01, 2024.
Open-market transactions through Jun 30, 2026most recent first
Mauch Robert P.10b5-1
President & CEO · Director
−$479.2K
Feb 18, 2026
1,333 sh · $359.46
Mauch Robert P.10b5-1
President & CEO · Director
−$1.8M
Jan 20, 2026
5,096 sh · $354.73
Campbell Elizabeth S
Executive Vice President
−$1.1M
Dec 19, 2025
3,351 sh · $342.10
Battaglia Silvana
Executive Vice President
−$578.6K
Dec 19, 2025
1,677 sh · $345.00
Mauch Robert P.10b5-1
President & CEO · Director
−$1.8M
Dec 18, 2025
5,096 sh · $343.45
Krikorian Lazarus
SVP & Chief Accounting Officer
−$1.4M
Dec 17, 2025
4,031 sh · $343.24
Mauch Robert P.10b5-1
President & CEO · Director
−$1.9M
Nov 18, 2025
5,096 sh · $366.64
Mauch Robert P.10b5-1
President & CEO · Director
−$1.7M
Oct 20, 2025
5,097 sh · $326.80
Campbell Elizabeth S10b5-1
Executive Vice President
−$590.8K
Oct 01, 2025
1,886 sh · $313.28
Mauch Robert P.10b5-1
President & CEO · Director
−$1.5M
Sep 18, 2025
5,097 sh · $290.00
Collis Steven H10b5-1
Executive Chairman · Director
−$9.1M
Sep 16, 2025
31,350 sh · $289.86
Collis Steven H10b5-1
Executive Chairman · Director
−$4.2M
Aug 19, 2025
14,579 sh · $289.98
Mauch Robert P.10b5-1
President & CEO · Director
−$1.5M
Aug 18, 2025
4,968 sh · $293.53
Collis Steven H10b5-1
Executive Chairman · Director
−$4.3M
Jul 22, 2025
14,578 sh · $292.67
Mauch Robert P.10b5-1
President & CEO · Director
−$1.5M
Jul 18, 2025
4,968 sh · $294.11
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Feb 18, 2026 | Mauch Robert P.10b5-1President & CEO · Director | 1,333 | $359.46 | −$479.2K |
| Jan 20, 2026 | Mauch Robert P.10b5-1President & CEO · Director | 5,096 | $354.73 | −$1.8M |
| Dec 19, 2025 | Campbell Elizabeth SExecutive Vice President | 3,351 | $342.10 | −$1.1M |
| Dec 19, 2025 | Battaglia SilvanaExecutive Vice President | 1,677 | $345.00 | −$578.6K |
| Dec 18, 2025 | Mauch Robert P.10b5-1President & CEO · Director | 5,096 | $343.45 | −$1.8M |
| Dec 17, 2025 | Krikorian LazarusSVP & Chief Accounting Officer | 4,031 | $343.24 | −$1.4M |
| Nov 18, 2025 | Mauch Robert P.10b5-1President & CEO · Director | 5,096 | $366.64 | −$1.9M |
| Oct 20, 2025 | Mauch Robert P.10b5-1President & CEO · Director | 5,097 | $326.80 | −$1.7M |
| Oct 01, 2025 | Campbell Elizabeth S10b5-1Executive Vice President | 1,886 | $313.28 | −$590.8K |
| Sep 18, 2025 | Mauch Robert P.10b5-1President & CEO · Director | 5,097 | $290.00 | −$1.5M |
| Sep 16, 2025 | Collis Steven H10b5-1Executive Chairman · Director | 31,350 | $289.86 | −$9.1M |
| Aug 19, 2025 | Collis Steven H10b5-1Executive Chairman · Director | 14,579 | $289.98 | −$4.2M |
| Aug 18, 2025 | Mauch Robert P.10b5-1President & CEO · Director | 4,968 | $293.53 | −$1.5M |
| Jul 22, 2025 | Collis Steven H10b5-1Executive Chairman · Director | 14,578 | $292.67 | −$4.3M |
| Jul 18, 2025 | Mauch Robert P.10b5-1President & CEO · Director | 4,968 | $294.11 | −$1.5M |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Cencora, Inc. company record
- SEC industry classification
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Headquarters
- Conshohocken, PA
- Incorporated in
- DE
- Listed on
- NYSE
- SEC Central Index Key
- 0001140859
- Previously filed as
- AMERISOURCEBERGEN CORP
Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.
After insiders bought COR
What the stock actually did in the 90 days following each open-market purchase
Don't check COR — let it ping you
Get told the moment an insider moves on COR
Pro watches Cencora, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add COR to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read COR insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- Are COR insiders buying or selling?
- Between Feb 20, 2026 and Sep 16, 2026, 6 Cencora, Inc. insiders made 3 open-market purchases worth $2.3M and 4 sales worth $5.7M, a net sale of $3.4M. 2 of the sales were pre-scheduled under a Rule 10b5-1 plan.
- How much COR stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 9 Cencora, Inc. insiders made 3 open-market purchases worth $2.3M and 50 sales worth $1.5B. 33 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 3 purchases ($2.3M) and 16 sales ($34.6M). The largest purchase was Durcan Dermot Mark buying $1.1M on Jun 18, 2026. The largest sale was Walgreens Boots Alliance Holdings LLC selling $1.1B on Aug 01, 2024.
- What was the largest recent COR insider trade?
- Campbell Elizabeth S (Executive Vice President) sold $3.7M of COR stock on Aug 24, 2026 at about $324.12 a share.
- When did an insider last buy COR shares?
- The most recent open-market purchase on file is Tyler Lauren M (Director) buying $148.6K on Jun 22, 2026. The largest purchase in the period was $1.1M by Durcan Dermot Mark.
- Where does COR insider trading data come from?
- From the Form 4 filings Cencora, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.
